BioPharm News

Apr 05, 2018
By BioPharm International Editors
The companies have created Syna Therapeutics, a joint venture that will develop biosimilars and new molecules.
Apr 03, 2018
By BioPharm International Editors
Pfizer transfers CAR-T assets to Allogene Therapeutics under a new alliance to further develop immuno-oncology therapeutics.
Apr 03, 2018
By BioPharm International Editors
The agency has accepted AstraZeneca’s biologics license application for an investigational leukemia drug candidate and granted it priority review.
Apr 03, 2018
By BioPharm International Editors
The agency has release a report providing an overview of steps taken to enhance benefit-risk assessment in the review of drugs.
Apr 03, 2018
By BioPharm International Editors
A new scientific publication examines analytical processes for the emerging legal cannabis industry.
Mar 30, 2018
By BioPharm International Editors
The company’s Krios G3i cryo-electron microscope is a finalist in the 2018 Edison Awards.
Mar 30, 2018
By BioPharm International Editors
The company’s close communication with customers has enabled it to bring advanced pipetting products to market.
Mar 30, 2018
By BioPharm International Editors
The contract research organization has added a new analytical laboratory in Middleton, WI, to expand its biologics testing capacity.
Mar 29, 2018
By BioPharm International Editors
Novartis’ Sandoz is seeking approval of its biosimilar referencing Johnson & Johnson’s Remicade (infliximab) for all of Remicade’s indications across gastroenterology, rheumatology, and dermatology.
Mar 29, 2018
By BioPharm International Editors
EMA has recommended approval of the biosimilar for the same indications as Roche’s Herceptin (trastuzumab).
native1_300x100
lorem ipsum